Internal Medicine · Baltimore, MD
NPI
1306059019
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
600 N Wolfe St, Brady 522b
Baltimore, MD, 21287
Phone (410) 583-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
803 services
Medicare patients, 2024
236
Average age 71
Drug cost, 2024
$1.6M
617 prescriptions
Company payments, 2025
$17K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher K Lippincott was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 121 times for 77 patients. In total Christopher K Lippincott billed 803 services in 23 codes, and Medicare paid $57K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 121 | 77 | $12.57 | $1,521 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 66 | $13.34 | $1,521 |
| 99215 Office E&M - Established | Facility | 89 | 62 | $106.10 | $9,443 |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 43 | $95.83 | $5,846 |
| 99214 Office E&M - Established | Office | 53 | 41 | $96.91 | $5,136 |
| 99232 Hospital E&M - Subsequent | Facility | 51 | 34 | $63.99 | $3,263 |
| 99215 Office E&M - Established | Office | 50 | 35 | $144.10 | $7,205 |
| 99222 Hospital E&M - Initial | Facility | 41 | 40 | $103.81 | $4,256 |
| 99214 Office E&M - Established | Facility | 39 | 33 | $68.92 | $2,688 |
| 99213 Office E&M - Established | Office | 39 | 29 | $69.48 | $2,710 |
| 99291 Critical Care E&M | Facility | 27 | 16 | $167.80 | $4,531 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 21 | 14 | $25.46 | $535 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 13 | $26.65 | $560 |
| 99213 Office E&M - Established | Facility | 18 | 12 | $50.73 | $913 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $138.36 | $1,799 |
By year: 2022 $51K for 485 services; 2023 $61K for 604 services; 2024 $57K for 803 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher K Lippincott prescribed most often to Medicare patients was Ethambutol Hcl, with 66 prescriptions and refills. In total Christopher K Lippincott wrote 617 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ethambutol Hcl Generic | 66 | 121 | 14 | $2,745 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 43 | 49 | Under 11 | $187K |
| Azithromycin Generic | 40 | 77 | 15 | $811 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 38 | 38 | Under 11 | $579K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 28 | 32 | 17 | $414 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 28 | 35 | 13 | $1,294 |
| Nuzyra Omadacycline Tosylate | 27 | 28 | Under 11 | $415K |
| Dovato Dolutegravir Sodium/Lamivudine | 22 | 22 | Under 11 | $65K |
| Tivicay Dolutegravir Sodium | 22 | 30 | Under 11 | $66K |
| Rosuvastatin Calcium Generic | 20 | 22 | Under 11 | $24.97 |
| Valacyclovir Valacyclovir Hcl | 19 | 31 | Under 11 | $882 |
| Doxycycline Hyclate Generic | 18 | 20 | Under 11 | $211 |
| Rifampin Generic | 17 | 34 | Under 11 | $1,732 |
| Ciprofloxacin Hcl Generic | 14 | 14 | 13 | $202 |
| Amoxicillin Generic | 12 | 12 | Under 11 | $67.24 |
Brand drugs: - claims; generic drugs: 346 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher K Lippincott $17K ($17K in general payments such as food, travel and fees) from 2 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $9,020.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 7 | $9,020 |
| Insmed, Inc. INSM | 10 | $7,679 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.